Sudden infant death-dysgenesis of the testes syndrome

Sudden infant death-dysgenesis of the testes syndrome (SIDDT), also known as sudden infant death with dysgenesis of the testes syndrome, is an extremely rare and severe autosomal recessive disorder caused by mutations in the TSPYL1 gene located on chromosome 6q22. This condition was first described in Old Order Amish families and is characterized by a combination of testicular dysgenesis in affected males and a high risk of sudden death during infancy. The syndrome primarily affects the autonomic nervous system, the endocrine system, and the reproductive system. Key clinical features include dysgenesis (abnormal development) of the testes in males, leading to undervirilization or ambiguous genitalia, along with profound autonomic nervous system dysfunction. Affected infants may experience episodes of bradycardia, apnea, and temperature instability, which can lead to sudden unexpected death, typically within the first year of life. Female patients may also be affected and can experience sudden death, though they lack the gonadal dysgenesis component. Additional features may include adrenal insufficiency and other signs of brainstem or autonomic dysfunction. There is currently no cure or specific treatment for SIDDT. Management is supportive and focuses on monitoring for life-threatening autonomic events, including the use of cardiorespiratory monitoring. Genetic counseling is recommended for affected families. The prognosis is very poor, with most affected infants dying in the first two years of life. The condition is classified under ICD-10 code G90.8, reflecting its primary categorization as a disorder of the autonomic nervous system.

Common questions about Sudden infant death-dysgenesis of the testes syndrome